<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The purpose of this study was to compare the predictive value for <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> (CHD) of the International <z:mp ids='MP_0002055'>Diabetes</z:mp> Federation (IDF) definition (with Asian criteria for central <z:hpo ids='HP_0001513'>obesity</z:hpo>) of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> with existing criteria of the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) in Chinese subjects with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: Subjects with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and without macrovascular diseases or <z:hpo ids='HP_0003774'>end-stage renal disease</z:hpo> were categorized by the criteria of the IDF and the NCEP ATP III </plain></SENT>
<SENT sid="2" pm="."><plain>CHD was defined as <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e>, coronary revascularization, <z:hpo ids='HP_0001635'>heart failure</z:hpo>, and <z:hpo ids='HP_0011420'>death</z:hpo> related to CHD </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Of 4,350 patients (aged 54.4 +/- 13.4 years; median follow-up period 7.1 [interquartile range 5.2-8.5] years), 65.9% had <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> according to either IDF or NCEP ATP III criteria </plain></SENT>
<SENT sid="4" pm="."><plain>The NCEP ATP III definition identified <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> in 786 subjects (18.1%) who did not fulfill the criteria of the IDF </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> and systolic blood pressure were predictors of CHD after adjustment for other confounding factors </plain></SENT>
<SENT sid="6" pm="."><plain>Compared with subjects without <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, the IDF criteria failed to predict CHD (hazard ratio 1.13 [95% CI 0.86-1.48], P = 0.374) </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, the NCEP ATP III definition (2.51 [1.80-3.50], P &lt; 0.001) predicted an increased risk of CHD with the NCEP-only group having the highest risk (2.49 [1.66-3.73], P &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: With established type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, the IDF definition of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> failed to identify a subgroup of patients who had the highest risk for CHD </plain></SENT>
<SENT sid="9" pm="."><plain>Practitioners must recognize the appropriate setting for its application </plain></SENT>
</text></document>